11 patientsEleven patients had nucleoside reverse transcriptase inhibitor resistance mutations, including M184V and T215Y.
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations
Gold tier: mechanically validated evidence, with its primary source.
6,677 evidence items · page 154 / 268
11 patientsEleven patients had nucleoside reverse transcriptase inhibitor resistance mutations, including M184V and T215Y.
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations
44.3 %The most common HIV testing points identifying HIV-positive children were outpatient departments (44.3%) and maternal/child health departments (29.9%).
KenyaVIH/sidaobserved 2017-2018published 2020PloS onePubMeddocument of 8 observations
8.52 working_daysIn a centralised laboratory-only network, the mean turnaround time ranged from 8.52 to 8.55 working days.
KenyaVIH/sidapublished 2024BMJ openPubMeddocument of 6 observations
16.7 %Systems-level ED-based HIV testing among all presenting patients increased from 16.7% pre-implementation to 23.0% post-implementation periods 1 and 2.
KenyaVIH/sidaobserved 6 March - 16 April 2023 (pre-implementation); 1 May - 20 August 2023 (post-implementation periods 1 and 2)published 2024HIV research & clinical practicePubMeddocument of 4 observations
50 per_100Between July 1993 and June 1994, over 50% of Plasmodium falciparum out-patient cases in Humera occurred between August and October.
Kenyapaludismeobserved July 1993 to June 1994published 1997East African medical journaleurope_pmcdocument of 5 observations
0.73 adjusted_relative_riskAfter adjusting for age, the relative risk of PSA detection at postmenopausal versus premenopausal visits was 0.73 (95% confidence interval: 0.47 to 1.14).
KenyaVIH/sidapublished 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 5 observations
0.76 g/dlMalaria control increased haemoglobin among children under 5 by, on average, 0.76 g/dl after a mean of 1-2 years of intervention.
Kenyapaludismepublished 2004Tropical medicine & international health : TM & IHeurope_pmcdocument of 2 observations
59 daysTime to completion of at least 3 enhanced adherence counseling sessions was 59.0 days before implementation of the standardized enhanced adherence counseling package.
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 12 observations
51 %Hypertension control at 90 days was 51% in the intervention group and 41% in the control group.
Kenyahypertension artériellepublished 2022PloS onePubMeddocument of 7 observations
401 individualsBetween April 2022 and February 2023, 401 adolescent girls and young women were enrolled after initiating PrEP through their post-abortion care provider in Kenya.
KenyaVIH/sidaobserved April 2022 to February 2023published 2024AIDS and behaviorPubMeddocument of 4 observations
5.4 %Of the 37 newly diagnosed cases in the intervention period, two (5.4%) had acute HIV infection (AHI).
Kenyaacute HIV infectionobserved 2017 and 2020published 2022HIV medicinePubMeddocument of 6 observations
3.629 odds_ratioCarriage of HbAS was associated with increased micro-platelets in children with P. falciparum malaria in Kisumu County, Western Kenya.
Kenyadrépanocytose · paludismepublished 2020BMC infectious diseasesPubMeddocument of 8 observations
49.5 %Central obesity prevalence was 49.5% among females.
Kenyacentral obesityobserved 2015published 2020The Pan African medical journalPubMeddocument of 26 observations
944 partnersAmong 2176 partners in the post-implementation period, 944 were offered a second HIV self-test (HIVST).
KenyaVIH/sidaobserved March 2021-June 2022published 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations
The Tambua Mapema Plus study was conducted in Kenya from 2017 to 2020.
KenyaVIH/sidaobserved 2017-2020published 2022BMJ openPubMeddocument of 8 observations
12,700,000 peopleIn 2019, more than 12.7 million people resided in communities where Plasmodium falciparum parasite prevalence was predicted to be ≥ 30%.
Kenyapaludismeobserved 2019published 2021PLOS global public healtheurope_pmcdocument of 11 observations
33.7 daysVihiga County had the shortest mean DNA-PCR turnaround time at 33.7 days in Vihiga, Bungoma, Kakamega and Busia counties in Kenya between January 2012 and June 2013.
KenyaVIH/sidaobserved January 2012 to June 2013published 2024PloS onePubMeddocument of 7 observations
80.9 %Among 220 female sex workers in Nairobi, 80.9% (178/220) reported any client-perpetrated violence in the past 12 months.
Kenyaclient-perpetrated violenceobserved past 12 monthspublished 2021Journal of the International AIDS SocietyPubMeddocument of 11 observations
75 %75% of CIN 1 cases that were upgraded to CIN 2 during consensus review expressed p16INK4a.
KenyaCIN 1 · CIN 2published 2021The Pan African medical journalPubMeddocument of 11 observations
35.7 %35.7% of patients had moderate diabetic ketoacidosis.
Kenyadiabetic ketoacidosisobserved 2013–2018published 2020Journal of diabetes researchPubMeddocument of 10 observations
2.89 aHRAmong patients switching to dolutegravir-containing regimens, those without a recent viral load test or with a preswitch viral load ≥1000 copies/mL had an adjusted hazard ratio of 2.89 for incident viral load ≥1000 copies/mL compared to those with preswitch viral load <200 copies/mL.
KenyaVIH/sidapublished 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations
65 %In Kenya, the viral load testing uptake among paediatric and adolescent patients improved from 65% to 96%.
KenyaVIH/sidapublished 2021BMC health services researchPubMeddocument of 5 observations
11 prevalence_ratioThe prevalence ratio for experienced stigma associated with self-disclosure was 11.0 (95% CI: 1.4–86).
KenyaVIH/sidapublished 2021AIDS and behaviorPubMeddocument of 13 observations
82 %For 851 children eligible for testing, the most common reason for having an unknown HIV status was that the child's mother was not tested for HIV or had tested HIV negative during pregnancy (82%).
KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 7 observations
28.3 pg/mlThe median (IQR) levels of IFN-γ were 28.3 (23.5–31.2) pg/ml in pLLV participants and 11.4 (8.8–14.8) pg/ml in virally suppressed participants on first-line cART.
KenyaVIH/sidapublished 2025The Pan African medical journalPubMeddocument of 11 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.